Skip to main content
Top
Published in: Heart and Vessels 2/2015

01-03-2015 | Case Report

Bioresorbable scaffolds for the treatment of in-stent restenosis

Authors: Oliver Dörr, Christoph Liebetrau, Jens Wiebe, Franziska Hecker, Johannes Rixe, Helge Möllmann, Christian Hamm, Holger Nef

Published in: Heart and Vessels | Issue 2/2015

Login to get access

Abstract

Percutaneous coronary intervention with bare-metal stents or drug-eluting stents can decrease clinical event rates compared with simple balloon angioplasty. However, stent implantation is often associated with subsequent restenosis. Bioresorbable coronary scaffolds provide short-term vessel scaffolding with drug delivery capability and are designed to avoid the long-term limitations of metallic stents such as late stent thrombosis and in-stent restenosis. To the best of our knowledge, we report the first case series of successful treatment of in-stent restenosis using bioresorbable scaffolds.
Literature
1.
go back to reference Stone G, Moses J, Ellis S, Schofer J, Dawkins K, Morice M, Colombo A, Schampert E, Grube E, Kirtane A, Cutlip D, Fahy M, Pocock S, Mehran R, Leon M (2007) Safety and efficacy of sirolimus and paclitaxel eluting coronary stents. N Engl J Med 356:998–1008CrossRefPubMed Stone G, Moses J, Ellis S, Schofer J, Dawkins K, Morice M, Colombo A, Schampert E, Grube E, Kirtane A, Cutlip D, Fahy M, Pocock S, Mehran R, Leon M (2007) Safety and efficacy of sirolimus and paclitaxel eluting coronary stents. N Engl J Med 356:998–1008CrossRefPubMed
2.
go back to reference Morice M, Serruys P, Sousa J, Fajadet J, Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780CrossRefPubMed Morice M, Serruys P, Sousa J, Fajadet J, Hayashi E, Perin M, Colombo A, Schuler G, Barragan P, Guagliumi G, Molnar F, Falotico R (2002) A randomised comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. N Engl J Med 346:1773–1780CrossRefPubMed
3.
go back to reference Otsuka Y, Nakamura M, Kokubu N, Tonooka A, Inoue K, Higami T (2012) Diffuse in-stent restenosis of CYPHER® stent due to hypersensitivity reaction confirmed by pathohistological findings. Heart Vessels 27(1):110–113CrossRefPubMed Otsuka Y, Nakamura M, Kokubu N, Tonooka A, Inoue K, Higami T (2012) Diffuse in-stent restenosis of CYPHER® stent due to hypersensitivity reaction confirmed by pathohistological findings. Heart Vessels 27(1):110–113CrossRefPubMed
4.
go back to reference Ikuta S, Kobuke K, Iwanaga Y, Nakauchi Y, Yamaji K, Miyazaki S (2013) Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography. Heart Vessels. doi:10.1007/s00380-013-0376-4 PubMed Ikuta S, Kobuke K, Iwanaga Y, Nakauchi Y, Yamaji K, Miyazaki S (2013) Difference in neointimal coverage at chronic stage between bare metal stent and sirolimus-eluting stent evaluated at stent-strut level by optical coherence tomography. Heart Vessels. doi:10.​1007/​s00380-013-0376-4 PubMed
5.
go back to reference Barbash IM, Waksman R (2011) Current status, challenges and future directions of drug-eluting balloons. Future Cardiol 7:765–774CrossRefPubMed Barbash IM, Waksman R (2011) Current status, challenges and future directions of drug-eluting balloons. Future Cardiol 7:765–774CrossRefPubMed
6.
go back to reference Diletti R, Farooq V, Girasis C, Bourantas C, Onuma Y, Heo JH, Gogas BD, van Geuns RJ, Regar E, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn RJ, Smits P, Koolen J, Meredith I, Li X, Miquel-Hebert K, Veldhof S, Garcia-Garcia HM, Ormiston JA, Serruys PW (2013) Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart 99(2):98–105CrossRefPubMed Diletti R, Farooq V, Girasis C, Bourantas C, Onuma Y, Heo JH, Gogas BD, van Geuns RJ, Regar E, de Bruyne B, Dudek D, Thuesen L, Chevalier B, McClean D, Windecker S, Whitbourn RJ, Smits P, Koolen J, Meredith I, Li X, Miquel-Hebert K, Veldhof S, Garcia-Garcia HM, Ormiston JA, Serruys PW (2013) Clinical and intravascular imaging outcomes at 1 and 2 years after implantation of absorb everolimus eluting bioresorbable vascular scaffolds in small vessels. Late lumen enlargement: does bioresorption matter with small vessel size? Insight from the ABSORB cohort B trial. Heart 99(2):98–105CrossRefPubMed
7.
go back to reference Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D (2009) A bioabsorbable everolimus-eluting coronary stentsystem (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897–910CrossRefPubMed Serruys PW, Ormiston JA, Onuma Y, Regar E, Gonzalo N, Garcia-Garcia HM, Nieman K, Bruining N, Dorange C, Miquel-Hébert K, Veldhof S, Webster M, Thuesen L, Dudek D (2009) A bioabsorbable everolimus-eluting coronary stentsystem (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet 373:897–910CrossRefPubMed
Metadata
Title
Bioresorbable scaffolds for the treatment of in-stent restenosis
Authors
Oliver Dörr
Christoph Liebetrau
Jens Wiebe
Franziska Hecker
Johannes Rixe
Helge Möllmann
Christian Hamm
Holger Nef
Publication date
01-03-2015
Publisher
Springer Japan
Published in
Heart and Vessels / Issue 2/2015
Print ISSN: 0910-8327
Electronic ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-013-0464-5

Other articles of this Issue 2/2015

Heart and Vessels 2/2015 Go to the issue